Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation.
Overview
- Graduate School, Hunan University of Chinese Medicine, Changsha, Hunan, China
- Department of Emergency, Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine), Changsha, Hunan, China
- Department of Neurology, Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine), Changsha, Hunan, China
Abstract
Background: Histone deacetylases (HDACs) regulate neuroprotection; however, Trichostatin A (TSA), an HDAC inhibitor, lacks clear molecular mechanisms and core targets in Alzheimer’s disease (AD), limiting clinical translation. This study aimed to decipher TSA’s AD-regulating network, screen core genes, and support AD early diagnosis and multi-target therapies.
Methods: TSA targets were computationally predicted. Five GEO AD datasets were analyzed for differential genes and core modules, and 130 machine learning algorithms were employed to identify core genes. Functional annotation, immune cell analysis, and single-cell expression profiling were conducted. Molecular docking and 100 ns molecular dynamics simulations verified TSA-protein interactions.
Results: 949 potential TSA targets were identified, overlapping with AD differential genes and enriching key pathways such as GABAergic synapse and tau phosphorylation. Eight machine learning-identified core genes (EFNA1, GABRB2, GABARAPL1, EGR1, CDK5, KCNC2, MET, GRIA2) exhibited a distinct AD expression pattern: synergistic downregulation of protective genes and unique upregulation of pathological EFNA1. These genes are implicated in neurotransmission, synaptic plasticity, tau clearance, and immune-neural crosstalk. Molecular dynamics simulations suggested TSA may not stably bind these candidates, implying its regulation relies on epigenetic mechanisms via HDAC1–3/
Conclusion: This study provides preliminary insights into TSA’s putative mechanisms in AD intervention, highlighting the eight candidate core genes’ potential diagnostic and therapeutic value as AD biomarkers, supporting TSA’s multi-target therapy. All findings are computationally derived and require experimental verification.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE161045, at NCBI GEO; found in the text, “3.7. Single-cell data UMAP dimensionality…”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “2.2. Collection and preprocessing of…”
Data Availability
All relevant data are within the paper and its Supporting Information files.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 9 MeSH terms, 2 funders, 75 references.
Cite
This paper
Ou, C., Chen, B., Deng, J., & Long, H. (2026). Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation. PloS one, 21(4), e0347532. https://
BibTeX
@article{ou2026decipheri
author = {Ou, Changze and Chen, Binbin and Deng, Jun and Long, Huajun},
title = {{Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation}},
journal = {PloS one},
year = {2026},
month = apr,
volume = {21},
number = {4},
pages = {e0347532},
publisher = {PLOS},
issn = {1932-6203},
doi = {10.1371/
url = {https://
pmid = {42008415},
pmcid = {PMC13094961}
}
RIS
TY - JOUR
AU - Ou, Changze
AU - Chen, Binbin
AU - Deng, Jun
AU - Long, Huajun
TI - Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation
T2 - PloS one
J2 - PLoS One
PY - 2026
DA - 2026/
VL - 21
IS - 4
SP - e0347532
SN - 1932-6203
PB - PLOS
DO - 10.1371/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1371/
"type": "article-journal",
"title": "Deciphering the molecular network of Trichostatin A in regulating Alzheimer's disease screening of core genes and mechanistic investigation based on multidimensional bioinformatics and molecular simulation",
"container-title": "PloS one",
"author": [
{
"family": "Ou",
"given": "Changze"
},
{
"family": "Chen",
"given": "Binbin"
},
{
"family": "Deng",
"given": "Jun"
},
{
"family": "Long",
"given": "Huajun"
}
],
"container-title-short":
"volume": "21",
"issue": "4",
"page": "e0347532",
"DOI": "10.1371/
"PMID": "42008415",
"PMCID": "PMC13094961",
"ISSN": "1932-6203",
"publisher": "PLOS",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
20
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-025-94188-7 [code]
- Connexin 43 is downregulated in advanced Parkinson's disease in multiple brain regions which correlates with symptoms.Journal: Scientific reportsIn common: NCBI GEO GSE161045
- [2] doi:10.1155/mi/4419137
- Rougan Tongluo Decoction Initiates Neuroprotection Against Cerebral Ischemia by Activating the Endogenous SLC6A8-Creatine-EARS2 Mitochondrial Pathway.Journal: Mediators of inflammationIn common: author Huajun Long
- [3] doi:10.1007/s12035-025-05608-8
- Unraveling Cannabidiol's Dual Modulatory Role in Schizophrenia: Network Pharmacology and In Vivo Validation of Neuroinflammatory and Behavioral Modulation.Journal: Molecular neurobiologyIn common: 3 references
- [4] doi:10.1002/alz.71378
- Human iPSC-derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model.Journal: Alzheimer's & dementia : the journal of the Alzheimer's AssociationIn common: Alzheimer's / dementia, 2 references
- [5] doi:10.1097/md.0000000000045715
- Identification of potential drug targets for Alzheimer's disease from genetic insights: A Mendelian randomization study.Journal: MedicineIn common: Alzheimer's / dementia, 2 references
- [6] doi:10.1016/j.heliyon.2023.e18008
- Transcriptome analysis identifies the role of Class I histone deacetylase in Alzheimer's disease.Journal: HeliyonIn common: Alzheimer's / dementia, 2 references
- [7] doi:10.1186/s12951-026-04551-7
- The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.Journal: Journal of nanobiotechnologyIn common: Alzheimer's / dementia, 2 references
- [8] doi:10.1073/pnas.2307776121 [code]
- A structurally precise mechanism links an epilepsy-associated &
lt;i& gt;KCNC2& lt;/ i& gt; potassium channel mutation to interneuron dysfunction. Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: 2 references - [9] doi:10.3390/brainsci14030275 [code]
- Gene Expression of GABA<sub>A</
sub> Receptor Subunits and Association with Patient Survival in Glioma. Journal: Brain sciencesIn common: 2 references - [10] doi:10.1186/s12967-026-08385-7
- Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.Journal: Journal of translational medicineIn common: 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
